Chunggei launches pioglitazone 15 mg

Published: 2008-12-29 06:31:00
Updated: 2008-12-29 06:31:00
Chunggei Pharm has launched pioglitazone 15 mg in a bid to expand its presence in domestic type 2 diabetes market under joint marketing with Schnell Pharmaceuticals Inc.

Pioglitazone is used with a diet and exercise program and sometimes with other medications, to treat type 2 diabetes.

P...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.